Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04495673 · ClinicalTrials.gov registry record · NA

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder

A NA study, sponsored by University of Minnesota.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT04495673 is a NA study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04495673, a NA study, was terminated before completion, sponsored by University of Minnesota.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcrancial direct current stimulation (tDCS) for new addiction treatments that support long-term abstinence. This study will investigate whether the pairing of dorsolateral prefrontal cortex (DLPFC) stimulation and cognitive training can enhance functional connectivity between DLPFC and nucleus accumbens (NAcc). We have identified higher functional connectivity between DLPFC and NAcc in alcoholics that have successfully maintained abstinence for extended periods of time (7 years). This paired-neuromodulation approach can potentially be used as a therapeutic intervention to decrease substance use probability in addiction (e.g. opioid use disorder). The long term goal is to develop new addiction treatments that support long-term abstinence in opioid use disorder. The overall objective of this proposal is to enhance functional connectivity between DLPFC and NAcc as a therapeutic intervention to enhance cognition and reduce substance use rates in opioid use disorder.

Interventions

  • DEVICE Transcranial Direct Current Stimulation (tDCS)
  • BEHAVIORAL Cognitive Training
  • DEVICE Sham Transcranial Direct Current Stimulation (tDCS)

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2021-01-11
Est. Completion 2022-02-22
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04495673

The ClinicalTrials.gov registry entry for NCT04495673 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT04495673 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04495673 about?

NCT04495673 is a clinical study titled "Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder". The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcrancial direct current stimulation (tDCS) for new addiction treatments that support long-t...

What is the current status of trial NCT04495673?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2021-01-11. Estimated completion is 2022-02-22.

What interventions are being tested in trial NCT04495673?

The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (DEVICE), Cognitive Training (BEHAVIORAL), Sham Transcranial Direct Current Stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT04495673?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.